Intrahospital cardiovascular complications in severe community-acquired pneumonia

A. Cilli (Antalya, Turkey)

Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Session: Discussion of vaccines, biomarkers and risk factors analysis  
Session type: Poster Discussion
Number: 4522
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Cilli (Antalya, Turkey). Intrahospital cardiovascular complications in severe community-acquired pneumonia. 4522

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016



Affecting factors of mortality in severe community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia
Source: Eur Respir J 2009; 34: 932-939
Year: 2009



Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009



Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016


Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections
Source: Eur Respir Monogr 2020; 88: 212-228
Year: 2020


Analysis of the mortality caused by community-acquired pneumonia in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005

Community-acquired pneumonia: treatment failure and complications
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Community-acquired pneumonia in the elderly requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004

Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019


COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Analysis of mortality from community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 376s
Year: 2006

Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007